The enteral feeding formulas market size is estimated to be USD 3,298.7 million in 2021 and is expected to witness a CAGR of 7.91% during the forecast period 2022-2032. The increased healthcare spending, a rise in preterm births worldwide, an ageing population that requires enteral feeding, an expansion in the incidence of chronic diseases like diabetes, cancer, gastrointestinal diseases, and neurological disorders are some of the key drivers for the market growth. However, lack of awareness is expected to restrain the market growth.

Segmentation

By Product

Based on product, the market is categorized into peptide formulas, standard formulas, and specialized formulas. In 2021, the standard formulas accounted for the highest revenue share due to rising need for low-cost nutrient formulations and the accessibility of numerous types of standard formula.

By Age

Based on age, the market is segmented into pediatric and adults. In 2021, the adults segment accounted for the largest revenue share owing to increase in the occurrence of chronic diseases and illnesses including neurological disorders and diseases.

By Application

On the basis of application, the market is categorized into neurology, oncology, gastroenterology, critical care, and diabetes. In the global market, the oncology segment accounted for the largest revenue share in 2021 owing to the high frequency of malnutrition among cancer patients.

By End User

Based on end user, the market is segmented into homecare, ambulatory surgical centres, and hospitals. In 2021, the hospitals segment accounted for the largest revenue share owing to surge in demand from critically ill patients and the growing prevalence of chronic diseases like diabetes, cancer, inflammatory bowel disease, and others.

Regional Markets

In 2021, North America region accounted for the highest revenue in the enteral feeding formulas market and is expected to maintain its dominance during the forecast period. This is attributed to rising elderly population, escalating prevalence of chronic diseases and disorders, rising healthcare costs, and increasing preference for homecare.

Competitor Insights

Some of the key players operating in the enteral feeding formulas market are Real Food Blends (US), Danone S.A. (France), Otsuka Holding Co. Ltd. (Japan), Nutritional Medicinals, LLC (US), Kate Farms (US), Fresenius Kabi (Germany), Victus, Inc. (US), Global Health Products, Inc. (US), Abbott (US), Hormel Foods Corporation (US), Medtrition Inc. (US), Reckitt Benckiser Group PLC. (UK), Nestlé S.A. (Switzerland), DermaRite Industries, LLC. (US), Meiji Holdings Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Medline Industries, LP. (US), and Ajinomoto Cambrooke, Inc. (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, age, application, and end user from 2021 to 2032.

Report Scope:

Segmentation: Enteral Feeding Formulas Market Report 2021- 2032

Product (Revenue, USD Million)

• Peptide Formulas
• Standard Formulas
• Specialized Formulas

Age (Revenue, USD Million)

• Pediatric
• Adults

Application (Revenue, USD Million)

• Neurology
• Oncology
• Gastroenterology
• Critical Care
• Diabetes

End user (Revenue, USD Million)

• Homecare
• Ambulatory Surgical Centres
• Hospitals

By Region (Revenue, USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA